Navigation Links
RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition
Date:5/1/2009

About Avalign Technologies, Inc.

Avalign Technologies, Inc. is a leading provider of outsourced services to medical device OEMs. Avalign provides its customers with a full-service offering including instruments, implants, and delivery systems. Avalign currently operates through four divisions, Instrumed International, Inc., Nemcomed, Inc., Advantis Medical, Inc., and NGInstruments, Inc. Instrumed is a premium-quality surgical instrument manufacturing and single-source sourcing expert. Nemcomed provides Avalign with precision machining capabilities and the ability to design and manufacture medical instruments and implants. Advantis is a leading orthopaedic case/tray system manufacturer providing Avalign's customers best-in-class delivery system capabilities. NGInstruments manufactures high quality surgical cutting tools, specializing in drills, taps, and reamers. More information about Avalign can be found at www.avaligntech.com.


'/>"/>
SOURCE Roundtable Healthcare Partners
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Stevens Health, Technology and Society roundtable: Sept. 19
2. NFIB Joins AARP, Business Roundtable and SEIU in Divided We Fail
3. Lucian Leape Institute Announces First Roundtable
4. OIG and HCCA Issue Government-Industry Roundtable Report
5. Lucian Leape Institute First Roundtable: A Resounding Success
6. Remarks By President Bush and President Kikwete of Tanzania at Roundtable on Pepfar
7. BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
8. Genomic Health to Participate in Leerink Swann Roundtable Conference
9. Privacy Experts Roundtable Report Will Highlight Privacy & Security Week
10. Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program
11. Caliper Life Sciences to Present at Leerink Swanns 3rd Annual Life Science Tools Roundtable Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel company launch... San Clemente, Calif. (PRWEB)...kthrough medical apparel, today announced the laun... Medica 2009, a leading international trade fair f...y. Medelita inaugurates its men,s collection with ...
(Date:11/21/2009)... Linwood Group ask whether there is a secr...ed? , London, UK (PRWEB) ...h up to one in three of the adult UK population dr...ng alcohol-related liver disease*, it is hardly a ...abilitation programmes and residential centres for...
(Date:11/20/2009)...ASHINGTON, Nov. 20 The ... the Senate to make essential changes its health r...n abortion funding and conscience protection on ab...ts and include strong provisions for adequate affo...lth care bill an "enormous disappointment" that cr...
(Date:11/20/2009)...O, Nov. 20 The American...d and Drug Administration (FDA) to establish appro...ls. ,, Citing concern about the safety of whit... the benefit of professional consultation or exami... application of chemically based tooth whitening o...
(Date:11/20/2009)...AS, Nov. 20 The followi...ctor of the Nevada Health Care Association: ,, ...s and thanks Senate Majority Leader Harry Reid for... toward our goal of protecting every Nevada senior...d preserving the strength and viability of our sta...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...lar disorder respond differently to facial express...according to a new study led by a Bradley Hospital...insight into the neurobiology of pediatric bipolar...isorder in kids, our understanding of its neurobio...
...versity of Pennsylvania School of Medicine and oth...ic stimulation (TMS) a non-invasive technique tha... passed through the scalp is a safe and effective...udy the largest to-date studying TMS as a standal...
...more dense breasts, , , MONDAY, Nov. 26 (H...pear to have more dense breast tissue than their s...ts. , The finding is potentially important because...n the United Kingdom, found that city-dwelling wom...
...king-related, and its there in bright medical imag... in the lungs, caused by secondhand cigarette smok... lung injury to nonsmokers that was long suspected...strict secondhand smoke. , We used a special typ...
...hers have identified structural damage to the lung...sults of the study, conducted by researchers at th...rlottesville and The Childrens Hospital of Philade...hat prolonged exposure to secondhand smoke may cau...
... RN, FAAN, FAHA, a clinical professor of neurology...d an investigator at the Framingham Heart Study, w...the American Heart Association (AHA). The award wa...ely work to integrate stroke and heart disease in ...
Other Medicine News:Health News:Facial expressions have greater impact on kids with bipolar disorder 2Health News:Penn research shows transcranial magnetic stimulation effective in treating major depression 2Health News:Urban Women May Have Greater Breast Cancer Risk 2Health News:Urban Women May Have Greater Breast Cancer Risk 3Health News:Secondhand smoke damages lungs, MRIs show 2Health News:Novel MRI technique shows secondhand smoke damages lungs 2
(Date:11/20/2009)... MINNEAPOLIS, Nov. 20 Bi...ults for its first quarter ended September 30, 200...ted share, on revenues of $3,263,000. This compar...ed share, on revenues of $3,168,000 for the first ...t quarter results, Biotel President and CEO Steve ...
(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstC... BDX ) today announced the completion of its acqu...based company that develops and manufactures molec..., In May 2009, BD and HandyLab announced an exc...ze molecular assays on the HandyLab Jaguar(TM) pla...
(Date:11/19/2009)..., ARDEE, Ireland, Nov. 19 Warner ...pricing of its previously announced secondary offe...ce to the public of $22.25 per share. The selling...apital Partners, DLJ Merchant Banking, J.P. Morgan...Lee Partners, L.P., certain other institutional in...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Lupin Expands Branded Play 5066 1Lupin Expands Branded Play 5066 2Lupin Expands Branded Play 5066 3Sexually satisfied women have better general well being and more vitality 58485 1Sexually satisfied women have better general well being and more vitality 58485 2Sexually satisfied women have better general well being and more vitality 58485 3Is trash the solution to tackling climate change 3F 14282 1
... Company Plans to Move Compound Forward into Phase...9:00 A.M., Eastern Time -, LA JOLLA, Calif., Oct.... ) today announced that tezampanel met the,primary...al for the,treatment of a single, acute migraine a...ministered subcutaneously, the 40 mg dose demonstr...
...WI Scientist Dr. Dan Gewirth,s Groundbreaking Rese...lecular Cell, BUFFALO, N.Y., Oct. 19 Dr. Dan Gew...has just solved the structure,of the first mammali...h as,sepsis, AIDS and certain cancers. His work is... scientific journal -- Molecular Cell. Gewirth,s ...
Other Medicine Technology:Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 2Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 3Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 4Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 5Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 6Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 7Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 8First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 2First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 3First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 4
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: